Click here to get full coverage on Immatics N.V. (NASDAQ:IMTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Immatics N.V. (NASDAQ:IMTX) Given Average Rating of "Moderate Buy" by Brokerages  MarketBeat

Immatics N.V. (NASDAQ:IMTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Click here to get full coverage on Discipline and Rules-Based Execution in IMTX Response - Stock Traders Daily

Discipline and Rules-Based Execution in IMTX Response  Stock Traders Daily

Discipline and Rules-Based Execution in IMTX Response - Stock Traders Daily

Click here to get full coverage on Immatics: PRAME Leader's Transition To Commercial Reality - Seeking Alpha

Immatics: PRAME Leader's Transition To Commercial Reality  Seeking Alpha

Immatics: PRAME Leader's Transition To Commercial Reality - Seeking Alpha

Click here to get full coverage on BofA Securities Maintains Immatics(IMTX.US) With Buy Rating, Raises Target Price to $17 - 富途牛牛

BofA Securities Maintains Immatics(IMTX.US) With Buy Rating, Raises Target Price to $17  富途牛牛

BofA Securities Maintains Immatics(IMTX.US) With Buy Rating, Raises Target Price to $17 - 富途牛牛

Click here to get full coverage on Immatics (IMTX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Immatics (IMTX) Reports Q3 Loss, Misses Revenue Estimates  Yahoo Finance

Immatics (IMTX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on How Immatics’ US$125 Million Follow-on Equity Raise At Immatics (IMTX) Has Changed Its Investment Story - simplywall.st

How Immatics’ US$125 Million Follow-on Equity Raise At Immatics (IMTX) Has Changed Its Investment Story  simplywall.st

How Immatics’ US$125 Million Follow-on Equity Raise At Immatics (IMTX) Has Changed Its Investment Story - simplywall.st

Click here to get full coverage on Immatics Announces $125 Million Underwritten Offering - GlobeNewswire

Immatics Announces $125 Million Underwritten Offering  GlobeNewswire

Immatics Announces $125 Million Underwritten Offering - GlobeNewswire

Click here to get full coverage on Immatics (NASDAQ: IMTX) to sell 12,500,000 shares at $10.00 in underwritten offering - Stock Titan

Immatics (NASDAQ: IMTX) to sell 12,500,000 shares at $10.00 in underwritten offering  Stock Titan

Immatics (NASDAQ: IMTX) to sell 12,500,000 shares at $10.00 in underwritten offering - Stock Titan

Click here to get full coverage on Immatics (NASDAQ:IMTX) Stock Price Down 8.8% - What's Next? - MarketBeat

Immatics (NASDAQ:IMTX) Stock Price Down 8.8% - What's Next?  MarketBeat

Immatics (NASDAQ:IMTX) Stock Price Down 8.8% - What's Next? - MarketBeat

Click here to get full coverage on Immatics N.V. Announces Agreement to Sell 12.5 Million Ordinary Shares in Underwritten Offering | IMTX Stock News - Quiver Quantitative

Immatics N.V. Announces Agreement to Sell 12.5 Million Ordinary Shares in Underwritten Offering | IMTX Stock News  Quiver Quantitative

Immatics N.V. Announces Agreement to Sell 12.5 Million Ordinary Shares in Underwritten Offering | IMTX Stock News - Quiver Quantitative

Click here to get full coverage on Immatics (NasdaqCM:IMTX) Valuation Check After Follow-On Share Offering Announcement - Yahoo Finance

Immatics (NasdaqCM:IMTX) Valuation Check After Follow-On Share Offering Announcement  Yahoo Finance

Immatics (NasdaqCM:IMTX) Valuation Check After Follow-On Share Offering Announcement - Yahoo Finance

Click here to get full coverage on Revenues Not Telling The Story For Immatics N.V. (NASDAQ:IMTX) After Shares Rise 28% - simplywall.st

Revenues Not Telling The Story For Immatics N.V. (NASDAQ:IMTX) After Shares Rise 28%  simplywall.st

Revenues Not Telling The Story For Immatics N.V. (NASDAQ:IMTX) After Shares Rise 28% - simplywall.st

Click here to get full coverage on Immatics: Multiple Clinical Catalysts In Q4'25 And 2026 (NASDAQ:IMTX) - Seeking Alpha

Immatics: Multiple Clinical Catalysts In Q4'25 And 2026 (NASDAQ:IMTX)  Seeking Alpha

Immatics: Multiple Clinical Catalysts In Q4'25 And 2026 (NASDAQ:IMTX) - Seeking Alpha

Click here to get full coverage on Should Immatics' (IMTX) New Clinical Data on IMA402 and IMA401 Prompt Fresh Investor Attention? - Yahoo Finance

Should Immatics' (IMTX) New Clinical Data on IMA402 and IMA401 Prompt Fresh Investor Attention?  Yahoo Finance

Should Immatics' (IMTX) New Clinical Data on IMA402 and IMA401 Prompt Fresh Investor Attention? - Yahoo Finance

Click here to get full coverage on Immatics (NASDAQ:IMTX) Upgraded at Wall Street Zen - MarketBeat

Immatics (NASDAQ:IMTX) Upgraded at Wall Street Zen  MarketBeat

Immatics (NASDAQ:IMTX) Upgraded at Wall Street Zen - MarketBeat

Click here to get full coverage on Immatics (NasdaqCM:IMTX) Valuation Check After Dilutive Follow-On Equity Offering and Sharp One-Day Share Price Drop - simplywall.st

Immatics (NasdaqCM:IMTX) Valuation Check After Dilutive Follow-On Equity Offering and Sharp One-Day Share Price Drop  simplywall.st

Immatics (NasdaqCM:IMTX) Valuation Check After Dilutive Follow-On Equity Offering and Sharp One-Day Share Price Drop - simplywall.st

Click here to get full coverage on Evaluating Immatics (NasdaqCM:IMTX) Valuation After Recent Volatility and Sector Momentum - Yahoo Finance

Evaluating Immatics (NasdaqCM:IMTX) Valuation After Recent Volatility and Sector Momentum  Yahoo Finance

Evaluating Immatics (NasdaqCM:IMTX) Valuation After Recent Volatility and Sector Momentum - Yahoo Finance

Click here to get full coverage on Here Is What You Need To Know Before Investing In Immatics N.V. (IMTX) - Yahoo Finance

Here Is What You Need To Know Before Investing In Immatics N.V. (IMTX)  Yahoo Finance

Here Is What You Need To Know Before Investing In Immatics N.V. (IMTX) - Yahoo Finance

Click here to get full coverage on Immatics (IMTX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Immatics (IMTX) Reports Q2 Loss, Misses Revenue Estimates  Yahoo Finance

Immatics (IMTX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on (IMTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily

(IMTX) Movement as an Input in Quant Signal Sets  Stock Traders Daily

(IMTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Click here to get full coverage on Immatics (NASDAQ: IMTX) names Amie Krause CPO to lead HR amid commercial-stage transition - Stock Titan

Immatics (NASDAQ: IMTX) names Amie Krause CPO to lead HR amid commercial-stage transition  Stock Titan

Immatics (NASDAQ: IMTX) names Amie Krause CPO to lead HR amid commercial-stage transition - Stock Titan

Click here to get full coverage on Is IMTX stock attractive for income investors - July 2025 Macro Moves & Low Risk High Win Rate Picks - ulpravda.ru

Is IMTX stock attractive for income investors - July 2025 Macro Moves & Low Risk High Win Rate Picks  ulpravda.ru

Is IMTX stock attractive for income investors - July 2025 Macro Moves & Low Risk High Win Rate Picks - ulpravda.ru

Click here to get full coverage on New Analyst Forecast: $IMTX Given $19.0 Price Target - Quiver Quantitative

New Analyst Forecast: $IMTX Given $19.0 Price Target  Quiver Quantitative

New Analyst Forecast: $IMTX Given $19.0 Price Target - Quiver Quantitative

Click here to get full coverage on Can IMTX stock resist sector downturns - Market Performance Report & High Conviction Buy Zone Alerts - ulpravda.ru

Can IMTX stock resist sector downturns - Market Performance Report & High Conviction Buy Zone Alerts  ulpravda.ru

Can IMTX stock resist sector downturns - Market Performance Report & High Conviction Buy Zone Alerts - ulpravda.ru

Click here to get full coverage on Immatics (NASDAQ: IMTX) proof-of-concept; IMA402 at 30% cORR, IMA401 29% in melanoma - Stock Titan

Immatics (NASDAQ: IMTX) proof-of-concept; IMA402 at 30% cORR, IMA401 29% in melanoma  Stock Titan

Immatics (NASDAQ: IMTX) proof-of-concept; IMA402 at 30% cORR, IMA401 29% in melanoma - Stock Titan

Click here to get full coverage on Immatics (NASDAQ: IMTX) posts Q3 2025 with $505.8M cash and PRAME pipeline progress - Stock Titan

Immatics (NASDAQ: IMTX) posts Q3 2025 with $505.8M cash and PRAME pipeline progress  Stock Titan

Immatics (NASDAQ: IMTX) posts Q3 2025 with $505.8M cash and PRAME pipeline progress - Stock Titan

Click here to get full coverage on (IMTX) Volatility Zones as Tactical Triggers - Stock Traders Daily

(IMTX) Volatility Zones as Tactical Triggers  Stock Traders Daily

(IMTX) Volatility Zones as Tactical Triggers - Stock Traders Daily

Click here to get full coverage on Will IMTX stock remain a Wall Street favorite - 2025 Technical Patterns & Weekly Breakout Stock Alerts - ulpravda.ru

Will IMTX stock remain a Wall Street favorite - 2025 Technical Patterns & Weekly Breakout Stock Alerts  ulpravda.ru

Will IMTX stock remain a Wall Street favorite - 2025 Technical Patterns & Weekly Breakout Stock Alerts - ulpravda.ru

Click here to get full coverage on Can IMTX stock sustain free cash flow growth - July 2025 Pullbacks & Technical Pattern Alert System - ulpravda.ru

Can IMTX stock sustain free cash flow growth - July 2025 Pullbacks & Technical Pattern Alert System  ulpravda.ru

Can IMTX stock sustain free cash flow growth - July 2025 Pullbacks & Technical Pattern Alert System - ulpravda.ru

Click here to get full coverage on Immatics: Taking Off On A PRAME Rocketship - Seeking Alpha

Immatics: Taking Off On A PRAME Rocketship  Seeking Alpha

Immatics: Taking Off On A PRAME Rocketship - Seeking Alpha

Click here to get full coverage on Is IMTX stock dividend yield sustainable - Forecast Cut & Short-Term High Return Ideas - ulpravda.ru

Is IMTX stock dividend yield sustainable - Forecast Cut & Short-Term High Return Ideas  ulpravda.ru

Is IMTX stock dividend yield sustainable - Forecast Cut & Short-Term High Return Ideas - ulpravda.ru

Click here to get full coverage on Immatics N.V. (NASDAQ:IMTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Immatics N.V. (NASDAQ:IMTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts  MarketBeat

Immatics N.V. (NASDAQ:IMTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Click here to get full coverage on Is IMTX stock dividend yield sustainable - 2025 Geopolitical Influence & Safe Entry Zone Identification - ulpravda.ru

Is IMTX stock dividend yield sustainable - 2025 Geopolitical Influence & Safe Entry Zone Identification  ulpravda.ru

Is IMTX stock dividend yield sustainable - 2025 Geopolitical Influence & Safe Entry Zone Identification - ulpravda.ru

Click here to get full coverage on Will IMTX stock remain a Wall Street favorite - Quarterly Trade Summary & Technical Analysis for Trade Confirmation - ulpravda.ru

Will IMTX stock remain a Wall Street favorite - Quarterly Trade Summary & Technical Analysis for Trade Confirmation  ulpravda.ru

Will IMTX stock remain a Wall Street favorite - Quarterly Trade Summary & Technical Analysis for Trade Confirmation - ulpravda.ru

Click here to get full coverage on IMTX: Guggenheim Raises Price Target Amidst Consistent 'Buy' Rat - GuruFocus

IMTX: Guggenheim Raises Price Target Amidst Consistent 'Buy' Rat  GuruFocus

IMTX: Guggenheim Raises Price Target Amidst Consistent 'Buy' Rat - GuruFocus

Click here to get full coverage on Immatics N.V. Appoints Venkat Ramanan, Ph.D. as Chief Financial Officer - Quiver Quantitative

Immatics N.V. Appoints Venkat Ramanan, Ph.D. as Chief Financial Officer  Quiver Quantitative

Immatics N.V. Appoints Venkat Ramanan, Ph.D. as Chief Financial Officer - Quiver Quantitative

Click here to get full coverage on Is Immatics (NASDAQ:IMTX) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Yahoo Finance

Is Immatics (NASDAQ:IMTX) the Best Biotech Penny Stock to Buy According to Hedge Funds?  Yahoo Finance

Is Immatics (NASDAQ:IMTX) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Yahoo Finance

Click here to get full coverage on Immatics Second Quarter 2025 Earnings: Misses Expectations - simplywall.st

Immatics Second Quarter 2025 Earnings: Misses Expectations  simplywall.st

Immatics Second Quarter 2025 Earnings: Misses Expectations - simplywall.st

Click here to get full coverage on Immatics Completes $116.5 Million Share Offering to Boost R&D - TipRanks

Immatics Completes $116.5 Million Share Offering to Boost R&D  TipRanks

Immatics Completes $116.5 Million Share Offering to Boost R&D - TipRanks

Click here to get full coverage on Immatics stock price target raised to $17 from $16 at Leerink Partners - Investing.com

Immatics stock price target raised to $17 from $16 at Leerink Partners  Investing.com

Immatics stock price target raised to $17 from $16 at Leerink Partners - Investing.com

Click here to get full coverage on Immatics Appoints Venkat Ramanan as Chief Financial Officer - GlobeNewswire

Immatics Appoints Venkat Ramanan as Chief Financial Officer  GlobeNewswire

Immatics Appoints Venkat Ramanan as Chief Financial Officer - GlobeNewswire

Click here to get full coverage on Immatics Announces $125 Million Underwritten Offering - TradingView — Track All Markets

Immatics Announces $125 Million Underwritten Offering  TradingView — Track All Markets

Immatics Announces $125 Million Underwritten Offering - TradingView — Track All Markets

Click here to get full coverage on Immatics NV Misses Revenue But Keeps Analyst Fans On Board - Finimize

Immatics NV Misses Revenue But Keeps Analyst Fans On Board  Finimize

Immatics NV Misses Revenue But Keeps Analyst Fans On Board - Finimize

Click here to get full coverage on Immatics Plans $125 Million Stock Offering - MarketScreener

Immatics Plans $125 Million Stock Offering  MarketScreener

Immatics Plans $125 Million Stock Offering - MarketScreener

Click here to get full coverage on Immatics Announces Full Year 2024 Financial Results and Business Update - GlobeNewswire

Immatics Announces Full Year 2024 Financial Results and Business Update  GlobeNewswire

Immatics Announces Full Year 2024 Financial Results and Business Update - GlobeNewswire

Click here to get full coverage on Biotech Immatics to raise $125M through ordinary share offering - MSN

Biotech Immatics to raise $125M through ordinary share offering  MSN

Biotech Immatics to raise $125M through ordinary share offering - MSN

Click here to get full coverage on Immatics Reveals Promising Results from IMA203CD8 Phase 1a Trial - TipRanks

Immatics Reveals Promising Results from IMA203CD8 Phase 1a Trial  TipRanks

Immatics Reveals Promising Results from IMA203CD8 Phase 1a Trial - TipRanks

Click here to get full coverage on Immatics NV earnings missed by €0.04, revenue fell short of estimates - Investing.com

Immatics NV earnings missed by €0.04, revenue fell short of estimates  Investing.com

Immatics NV earnings missed by €0.04, revenue fell short of estimates - Investing.com

Click here to get full coverage on Immatics Announces $125 Million Underwritten Offering - The Manila Times

Immatics Announces $125 Million Underwritten Offering  The Manila Times

Immatics Announces $125 Million Underwritten Offering - The Manila Times

Click here to get full coverage on Immatics: A Promising TCR Pipeline (NASDAQ:IMTX) - Seeking Alpha

Immatics: A Promising TCR Pipeline (NASDAQ:IMTX)  Seeking Alpha

Immatics: A Promising TCR Pipeline (NASDAQ:IMTX) - Seeking Alpha

Click here to get full coverage on Here's Why Immatics N.V.'s (NASDAQ:IMTX) CEO Compensation Is The Least Of Shareholders' Concerns - Yahoo Finance

Here's Why Immatics N.V.'s (NASDAQ:IMTX) CEO Compensation Is The Least Of Shareholders' Concerns  Yahoo Finance

Here's Why Immatics N.V.'s (NASDAQ:IMTX) CEO Compensation Is The Least Of Shareholders' Concerns - Yahoo Finance

Click here to get full coverage on Immatics Announces Pricing of $150 Million Public Offering - GlobeNewswire

Immatics Announces Pricing of $150 Million Public Offering  GlobeNewswire

Immatics Announces Pricing of $150 Million Public Offering - GlobeNewswire

Click here to get full coverage on IMTX Stock Price and Chart — NASDAQ:IMTX - TradingView — Track All Markets

IMTX Stock Price and Chart — NASDAQ:IMTX  TradingView — Track All Markets

IMTX Stock Price and Chart — NASDAQ:IMTX - TradingView — Track All Markets

Click here to get full coverage on Why Immatics Stock Is Soaring Today - The Motley Fool

Why Immatics Stock Is Soaring Today  The Motley Fool

Why Immatics Stock Is Soaring Today - The Motley Fool

Click here to get full coverage on Immatics (IMTX) Stock Price, News & Analysis - MarketBeat

Immatics (IMTX) Stock Price, News & Analysis  MarketBeat

Immatics (IMTX) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on Immatics Announces Completion of Business Combination and Listing on NASDAQ - GlobeNewswire

Immatics Announces Completion of Business Combination and Listing on NASDAQ  GlobeNewswire

Immatics Announces Completion of Business Combination and Listing on NASDAQ - GlobeNewswire

Click here to get full coverage on Immatics Biotechnologies completes blank-check deal with Arya Sciences Acquisition Corp., begins trading - The Business Journals

Immatics Biotechnologies completes blank-check deal with Arya Sciences Acquisition Corp., begins trading  The Business Journals

Immatics Biotechnologies completes blank-check deal with Arya Sciences Acquisition Corp., begins trading - The Business Journals

Click here to get full coverage on Immatics (NASDAQ:IMTX) Stock Price Up 3.9% – Should You Buy? - Defense World

Immatics (NASDAQ:IMTX) Stock Price Up 3.9% – Should You Buy?  Defense World

IMTX

Price Chart

Key Statistics

Technicals

About IMTX

Latest News

Immatics N.V. (NASDAQ:IMTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Discipline and Rules-Based Execution in IMTX Response - Stock Traders Daily

Immatics: PRAME Leader's Transition To Commercial Reality - Seeking Alpha

Advanced Charts

Top Gainers

Top Losers